Pfizer says mid-November is earliest it can seek coronavirus vaccine approval

WorldNews

Published

NEW YORK — Pharmaceutical giant Pfizer says that the earliest it can request emergency authorization of its COVID-19 vaccine is the third week of November — and that’s if everything goes well. Despite President Trump’s repeated promises of a vaccine before election day, scientists have been cautioning that it’s unlikely that data showing a shot actually works would come until November or December. Moderna, another leading U.S. contender in the race to come up with an effective vaccine, previously announced that the earliest it could seek authorization of its own candidate would be Nov. 25. Pfizer CEO Albert Bourla has long said it’s possible that testing might reveal by the end of...

Full Article